Insertion of correct bases opposite the lesion by POLH

Stable Identifier
Reaction [transition]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

DNA polymerase eta (POLH) correctly incorporates two adenine deoxyribonucleotides (dAMPs) opposite a TT-CPD (thymine-thymine cyclobutane pyrimidine dimer) lesion. POLH can bypass other types of lesions, such as AP sites and cisplatin-induced intrastrand cross-linked gunanines, preferentially incorporating dAMPs and dGMPs opposite the lesion. While POLH is accurate in translesion synthesis (TLS) across thymine dimers, POLH has a low fidelity in TLS across other DNA damage types and when copying undamaged DNA. One of the protective mechanisms against POLH-induced mutagenesis may be that POLH cannot continue chain elongation after an incorrect nucleotide is incorporated (Matsuda et al. 2000, Masutani et al. 2000).

Literature References
PubMed ID Title Journal Year
10856253 Mechanisms of accurate translesion synthesis by human DNA polymerase eta.

Kusumoto, R, Iwai, S, Masutani, C, Hanaoka, F

EMBO J 2000
10801132 Low fidelity DNA synthesis by human DNA polymerase-eta

Kunkel, TA, Masutani, C, Matsuda, T, Bebenek, K, Hanaoka, F

Nature 2000
Catalyst Activity

DNA-directed DNA polymerase activity of POLH:MonoUb:K164-PCNA:RPA:RFC:TT-CPD-DNA Template [nucleoplasm]

Orthologous Events
Cite Us!